OFDT's working organization

 

Units


The French Monitoring Centre is organised into four scientific units and two transversal supporting units:

Scientific units:

- Indicators

- Surveys and Statistical Analysis

- Emerging Trends and New Drugs

- Public Policy Evaluation

Transversal units:

- Information and Communication

- Financial and Human Resources

Our organisational breakdown is detailed below on the chart. To see "who's who" in our permanent staff click here.

 

Organisational chart (January 2020)

 

Management Board

Chairperson:
Christine d'AUTUME

Vice-Chairperson:
Nicolas PRISSE, MD

 

Scientific College

Chairperson:
Bruno FALISSARD, MD, PhD

 

Julien
MOREL d'ARLEUX

Director

 

Ivana
OBRADOVIC

Deputy director

 

Julie-Émilie ADÈS
Media relations

 
 
 

General Matters

Virginie
MARTIN

Head of General Matters

 

Administration

Mickaël
DA SILVA

Assistant

 

Indicators


Christophe
PALLE


Head of unit

Anne-Claire
BRISACIER

Project manager

Marc-Antoine
DOUCHET

Project manager









 

Surveys and Statistical Analysis

Stanislas
SPILKA


Head of unit

Eric
JANSSEN

Project manager

Olivier
LE NÉZET

Project manager

Antoine
PHILIPPON

Project manager

Aurélia
ROVERSI

Project manager




 

Public Policy Evaluation

Cristina
DĺAZ-GÓMEZ


Head of unit

Maïtena
MILHET

Project manager

Carine
MUTATAYI

Project manager

Caroline
PROTAIS

Project manager






 

Emerging Trends and New Drugs

Agnès
CADET TAÏROU


Head of unit

Victor
DETREZ

Chargé d’études

Michel
GANDILHON

Project manager

Clément
GÉROME
Project Manager

Magali
MARTINEZ

Project manager




 

Information and Communication

Julie-Émilie
ADÈS


Head of unit

Thierry
DELPRAT

Webmaster

Anne
de l’EPREVIER

Documentalist

Isabelle
MICHOT

Documentalist

Frédérique
MILLION

Graphic designer




 

Financial and Human Resources

Pierre
PIQUEMAL-LAGORRE

Accountant

Laurence
GRANDJEAN

Deputy accountant

Mickaël
DA SILVA

Accounting assistant









Drugs in Europe


2019 EMCDDA European Drug Report

miniEDR2019s.jpgWhat do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.

  Country drug reports 2019

miniCountryProfiles.jpgDeveloped by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.